Cencora, Inc. $COR Shares Sold by Vinva Investment Management Ltd

Vinva Investment Management Ltd reduced its position in shares of Cencora, Inc. (NYSE:COR) by 9.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,581 shares of the company’s stock after selling 4,461 shares during the quarter. Vinva Investment Management Ltd’s holdings in Cencora were worth $13,426,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of COR. United Bank raised its holdings in Cencora by 4.5% in the 2nd quarter. United Bank now owns 7,032 shares of the company’s stock worth $2,109,000 after purchasing an additional 305 shares during the period. Crestwood Advisors Group LLC boosted its position in Cencora by 18.9% during the second quarter. Crestwood Advisors Group LLC now owns 1,376 shares of the company’s stock worth $413,000 after purchasing an additional 219 shares in the last quarter. Savant Capital LLC grew its holdings in Cencora by 8.4% in the second quarter. Savant Capital LLC now owns 8,251 shares of the company’s stock valued at $2,474,000 after purchasing an additional 639 shares during the period. Vestmark Advisory Solutions Inc. purchased a new stake in shares of Cencora in the second quarter valued at approximately $4,233,000. Finally, Fox Run Management L.L.C. purchased a new stake in shares of Cencora in the second quarter valued at approximately $448,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Cencora

In related news, CEO Robert P. Mauch sold 5,096 shares of Cencora stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the transaction, the chief executive officer owned 66,726 shares in the company, valued at approximately $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Silvana Battaglia sold 1,677 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $345.00, for a total value of $578,565.00. Following the transaction, the executive vice president directly owned 18,796 shares in the company, valued at $6,484,620. This trade represents a 8.19% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,220 shares of company stock worth $5,282,867 in the last ninety days. Insiders own 0.38% of the company’s stock.

Cencora Price Performance

Shares of NYSE COR opened at $357.98 on Friday. The firm has a 50-day simple moving average of $354.16 and a 200-day simple moving average of $336.45. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The stock has a market capitalization of $69.64 billion, a price-to-earnings ratio of 43.03, a price-to-earnings-growth ratio of 1.67 and a beta of 0.68. Cencora, Inc. has a 52 week low of $251.94 and a 52 week high of $377.54.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The firm had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. During the same period in the previous year, the business posted $3.73 earnings per share. Cencora’s quarterly revenue was up 5.5% on a year-over-year basis. On average, equities analysts predict that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Friday, February 13th. Cencora’s payout ratio is currently 28.85%.

Analyst Ratings Changes

COR has been the subject of several research analyst reports. JPMorgan Chase & Co. upped their target price on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Bank of America cut their price target on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a report on Monday, January 5th. Robert W. Baird set a $415.00 price objective on shares of Cencora in a research report on Tuesday, January 13th. Barclays increased their price objective on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Finally, Wall Street Zen lowered shares of Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. Eleven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $399.00.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.